B

Active Director Additional Director DIN 11334434
DIN 11334434 First appointment Oct 2025 Primary industry Packaging
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Bijumon

Data last updated:

Bijumon is an Additional Director at Rxsterile Medpack Private Limited (since 2025). The company operates in Packaging.

DIN 11334434
Primary Designation Additional Director
Industry Packaging
First Appointment 20 Oct 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rxsterile Medpack Private Limited U32509KL2025PTC096642
Additional Director20 Oct 2025Active

Directorship timeline

Open interactive timeline →
Rxsterile Medpack Private Limited
Premium access

Shareholding and investment profile for Bijumon

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bijumon

Bijumon currently holds 1 directorship: Rxsterile Medpack Private Limited (Additional Director, since 20 Oct 2025).

Bijumon was first appointed on 20 Oct 2025 as Additional Director at Rxsterile Medpack Private Limited.

The current boards of Bijumon's companies include Babu Nadukkandi (Rxsterile Medpack Private Limited), Janardhanan Kannanghate (Rxsterile Medpack Private Limited), Preji Viruppil (Rxsterile Medpack Private Limited), Proja Babu (Rxsterile Medpack Private Limited), Sivakumar Kolleroth (Rxsterile Medpack Private Limited), Vincent Thomas (Rxsterile Medpack Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available